Survival, mortality and causes of death in inflammatory myopathies

Autoimmunity

Volumn 39, Issue 3, 2006, Pages 205-215

  Torres, Carmen ^a   Belmonte, Rebeca ^a   Carmona, Loreto ^b   Gómez Reino, F Javier ^a   Galindo, María ^a   Ramos, Belén ^a   Cabello, Ana ^a   Carreira, Patricia E ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIDAD DE INVESTIGACIÓN   (Spain)

Author keywords

Inflammatory myopathies; Mortality; Risk factors for mortality; Survival

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; METHOTREXATE;

ADULT; ARTICLE; CAUSE OF DEATH; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DERMATOMYOSITIS; DISEASE CLASSIFICATION; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HEART LEFT VENTRICLE FAILURE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MYOSITIS; POLYMYOSITIS; POPULATION DISTRIBUTION; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SPAIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE;

EID: 33745074082     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930600622603     Document Type: Article

References (26)

1. Medsger, TA and Robinson, H and Masi, AT. (1971) Factors affecting survivorship in polymyositis: A life table study of 124 patients Arthritis Rheum, 14, pp. 249-258.
2. Benbassat, J and Gefel, D and Larholt, K and Sukenik, S and Morgenstrern, V and Zlotnick, A. (1985) Prognostic factors in polymyositis/dermatomyositis. A computer assisted analysis of ninety-two cases Arthritis Rheum, 28, pp. 249-255.
3. Maugars, YM and Berthelot, JMM and Abbas, AA and Mussini, JMB and Nguyen, JMD and Prost, AM. (1996) Long term prognosis of 69 patients with dermatomyositis or polymyositis Clin Exp Rheumatol, 14, pp. 263-274.
4. Marie, I and Hachulla, E and Hatron, PY and Hellot, MF and Levesque, H and Devulder, B and Courtois, H. (2001) Polymyositis and dermatomyositis: Short term and long term outcome, and predictive factors of prognosis J Rheumatol, 28, pp. 2230-2237.
5. Sultan, SM and Ioannou, Y and Moss, K and Isenberg, DA. (2002) Outcome in patients with idiopathic inflammatory myositis: Morbidity and mortality Rheuamtology, 41, pp. 22-26.
6. Dankó, K and Ponyi, A and Constantin, T and Borgulya, G and Szegedi, G. (2004) Long term survival of patients with idiopathic inflammatory myopathies according to clinical features. A longitudinal study of 162 cases Medicine, 83, pp. 35-42.
7. Chinoy, H and Ollier, WER and Cooper, RG. (2004) Have recent immunogenetic investigations increased our understanding of disease mechanisms in the idiopathic inflammatory myopathies? Curr Opin Rheumatol, 16, pp. 707-713.
8. Bohan, A and Peter, JB. (1975) Polymyositis and dermatomyositis. Parts 1 and 2 New Engl J Med, 292, pp. 344-347. 403-7
9. Askanas, V and Engel, WK. (1993) New advances in inclusion body myositis Curr Opin Rheumatol, 5, pp. 732-741.
10. Bohan, A and Peter, JB and Bowman, RL and Pearson, CM. (1977) A computer-assisted analysis of 153 patients with polymyositis and dermatomyositis Medicine, 56, pp. 255-286.
11. Huber, AM and Lang, B and LeBlanc, CMA and et al. (2000) Medium and long term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis Arthritis Rheum, 43, pp. 541-549.
12. Ponyi, A and Constantin, T and Balogh, Z and et al. (2005) Disease course, frequency of relapses and survival of 73 patients with juvenile or adult dermatomyositis Clin Exp Rheumatol, 23, pp. 50-56.
13. Rider, LG and Miller, FW and Targoff, IN and et al. (1994) A broadened spectrum of juvenile myositis. Myositis-specific autoantibodies in children Arthritis Rheum, 37, pp. 1534-1538.
14. Garton, MJ and Isenberg, DA. (1997) Clinical features of lupus myositis versus idiopathic myositis: A review of 30 cases Br J Rheumatol, 36, pp. 1067-1074.
15. Hochberg, MC and Feldman, D and Stevens, MB. (1986) Adult onset polymyositis/dermatomyositis: An analysis of clinical and laboratory features and survival in 76 patients with a review of the literature Sem Arthritis Rheum, 15, pp. 168-178.
16. Grau, JM and Miró, O and Pedrol, E and (1996) Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement J Rheumatol, 23, pp. 1921-1926.
17. Marie, I and Hachulla, E and Chérin, P and et al. (2002) Interstitial lung disease in polymyositis and dermatomyositis Arthritis Care Res, 47, pp. 614-622.
18. Schnabel, A and Reuter, M and Biederer, J. (2003) Interstitial lung disease in polymyositis and dermatomyositis: Clinical course and response to treatment Sem Arthritis Rheum, 32, pp. 273-284.
19. Fathi, M and Dastmalchi, M and Rasmussen, E and Lundberg, IE and Tornling, G. (2004) Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis Ann Rheum Dis, 63, pp. 297-301.
20. Wakata, N and Kurihara, T and Saito, E and Kinoshita, M. (2002) Polymyositis and dermatomyositis associated with malignancy: A 30 year retrospective study J Dermatol, 41, pp. 729-734.
21. Hill, CL and Zhnag, Y and Sigurgeirsson, B and Pukkala, E and Mellenkjaer, L and Airio, A and Evans, SR. (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: A population based study Lancet, 357, pp. 96-100.
22. Buchbinder, R and Forbes, A and Hall, S and Dennet, X and Giles, G. (2001) Incidence of malignant disease in biopsy proven inflammatory myopathy. A population based cohort study Ann Intern Med, 134, pp. 1087-1095.
23. Callen, JP. (2001) Relationship between dermatomyositis and polymyositis and cancer Lancet, 357, pp. 85-86.
24. Scussel-Lonzetti, L and Joyal, F and Raynauld, JP and et al. (2002) Predicting mortality in systemic sclerosis. Analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival Medicine, 81, pp. 154-167.
25. Ferri, C and Valentini, G and Cozzi, F and et al. (2002) Systemic sclerosis. Demographic, clinical and serological features and survival in 1012 Italian patients Medicine, 81, pp. 139-153.
26. Follansbee, WP and Zerbe, TR and Medsger, TA. (1993) Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association Am Heart J, 125, pp. 194-203.